Utilizing CRISPR-Cas Systems to Combat Antibacterial Resistance

About this Research Topic

Background

The escalating crisis of antimicrobial resistance (AMR) represents an existential threat to global health. The emergence and rapid global dissemination of "superbugs" capable of evading multiple antibiotics severely undermine our ability to treat common infections, threatening to revert modern medicine to a pre-antibiotic era where routine medical procedures become unacceptably risky. This challenge is multifaceted, driven by antibiotic misuse, inadequate infection control, and a critical shortfall in the development of genuinely novel antimicrobial agents. With millions of deaths directly attributable to resistant infections each year, the urgent need for innovative, precise, and multi-pronged strategies is paramount.

In this critical context, CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated proteins) systems have emerged as a groundbreaking and remarkably versatile paradigm for combating bacterial threats. Originally discovered as bacterial adaptive immune systems, CRISPR-Cas technologies have been ingeniously repurposed into highly precise and programmable genetic tools. Their unparalleled ability to specifically target and manipulate DNA or RNA sequences offers unprecedented avenues not only to directly disarm resistant bacteria but also to develop entirely new antibacterial modalities and enhance host defenses.

Beyond the direct degradation of antibiotic resistance genes (ARGs) on mobile genetic elements or bacterial chromosomes, CRISPR-Cas systems provide powerful means to disrupt essential bacterial genes for direct killing, interfere with bacterial communication and virulence, and even modulate host immune responses to improve infection clearance. Their programmable nature allows for the rational design of highly specific therapeutics. Furthermore, CRISPR's inherent connection to bacteriophages opens unique avenues for targeted delivery and synergistic therapies, while its precision makes it invaluable for rapid diagnostics and surveillance of resistant pathogens.

While the therapeutic and diagnostic promise of CRISPR-Cas is immense, practical challenges persist, including efficient and specific delivery into target cells, ensuring system stability in vivo, and mitigating potential off-target effects. Understanding and overcoming these hurdles, along with anticipating bacterial resistance mechanisms to CRISPR-based interventions, are crucial for successful clinical translation. This special issue aims to provide a comprehensive collection of cutting-edge research and insightful reviews that explore the full spectrum of CRISPR-Cas applications, from foundational mechanisms and computational design to innovative delivery, advanced diagnostics, and critical clinical considerations, in the global imperative to combat antibacterial resistance.

Suggested sub-topics:

1. Mechanisms of CRISPR-Cas Action against Antibiotic Resistance Genes (ARGs): Deep dives into how different CRISPR-Cas types (e.g., Type I, II, V, VI) are engineered for precise targeting and degradation of plasmid-borne or chromosomal ARGs, including CRISPR-mediated gene deletion and repression (CRISPRi).

2. CRISPR-Cas as a Direct Antibacterial Agent: Targeting Essential Bacterial Genes and Metabolic Pathways: Research on utilizing CRISPR-Cas to disrupt fundamental bacterial processes, leading to cell death or growth inhibition, thereby providing novel drug-independent antibacterial strategies.

3. Modulating Bacterial Virulence Factors, Biofilms, and Communication Systems: Studies on CRISPR-Cas applications to interfere with bacterial pathogenicity, including the suppression of virulence gene expression, inhibition of biofilm formation, interference with quorum sensing mechanisms, and targeting of drug efflux pumps.

4. Targeting Host Factors Modulating Bacterial Survival, Growth, and Immune Evasion: Investigations into using CRISPR-Cas or CRISPR-based screens to identify and modulate host genes or pathways that facilitate bacterial persistence (e.g., intracellular survival), promote immune evasion, or otherwise contribute to infection pathogenesis.

5. Enhancing Host Immune Responses for Bacterial Clearance via CRISPR-Cas: Studies on CRISPR-mediated modulation of host immune cells (e.g., macrophages, neutrophils) or specific immune pathways to bolster intrinsic anti-bacterial defenses, mitigate hyperinflammation, and improve overall host resilience against resistant infections.

6. CRISPR-Cas for Antibiotic Repurposing and Sensitization: Explorations into strategies where CRISPR-Cas systems are employed to restore the susceptibility of resistant bacterial strains to conventional antibiotics, thus revitalizing the efficacy of currently ineffective drugs.

7. Advanced Delivery Strategies for CRISPR-Cas Antimicrobials: Innovations in designing and optimizing delivery platforms for CRISPR-Cas components (e.g., engineered phages, nanoparticles, bacterial outer membrane vesicles, liposomes) to achieve targeted delivery, stability, and efficacy in vivo.

8. CRISPR-Phage Synergies and Engineering for Antimicrobial Applications: Research on the combined use of CRISPR-Cas with bacteriophages, including phage-mediated delivery of CRISPR components and the engineering of phages with enhanced lytic capabilities or broadened host ranges using CRISPR tools.

9. CRISPR-Based Diagnostics and Surveillance for AMR: Applications of CRISPR-Cas systems in developing rapid, sensitive, and specific diagnostics for identifying resistant bacterial strains, detecting ARGs in clinical samples, and facilitating surveillance of AMR dissemination.

10. Computational Design, Optimization, and In Silico Analysis of CRISPR Systems: Methodological advancements in bioinformatics and computational approaches for designing optimal guide RNAs, predicting off-target effects, analyzing bacterial resistance mechanisms to CRISPR, and simulating CRISPR-Cas therapeutic outcomes.

11. Challenges, Bacterial Resistance Mechanisms to CRISPR-Cas, and Counter-Strategies: Studies investigating potential bacterial countermeasures against CRISPR-Cas therapies (e.g., anti-CRISPR proteins, PAM mutations, target gene mutations) and the development of strategies to overcome these emerging resistances.

12. Clinical Translation, Safety, and Regulatory Considerations: Comprehensive reviews and original research on the current status of CRISPR-Cas-based antibacterial therapies from bench to bedside, detailed safety assessments, ethical implications, and the regulatory pathways for their eventual clinical adoption.

In this Research Topic we welcome the following article types: Original Research, Review, Mini Review, Perspective and Methods.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Editorial
• Hypothesis and Theory
• Methods
• Mini Review
• Opinion
• Original Research
• Perspective
• Review
• Systematic Review
• ... View all formats

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Editorial
• Hypothesis and Theory
• Methods
• Mini Review
• Opinion
• Original Research
• Perspective
• Review
• Systematic Review
• Technology and Code

Keywords: CRISPR-Cas, Antimicrobial Resistance (AMR), Bacterial Pathogens, Gene Editing, Host-Directed Therapies, Bacteriophages

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

• What is a Research Topic?

  Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

  Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

• Why does Frontiers publish Research Topics? 

  The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

  Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

• Why are Research Topics important for journals?

  As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

  A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

• How do we ensure the quality of articles within Research Topics?

  Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

  In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

• What are the benefits of publishing my article in a Research Topic?

  Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

  As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

  Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

   
• What types of articles can be published in a Research Topic?

  Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

  Check available article types here 

• Can I suggest a new Research Topic? 

  Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

  Suggest your topic here 

• Who leads a Research Topic? 

  A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

  The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

• What is the role of a topic editor?

  As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

   

  You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

• What support will I receive when editing a new Research Topic? 

  As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

• As a junior researcher, can I be involved in editing a Research Topic? 

  If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

• Can I get a certificate for editing a Research Topic?

  Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

• Who will I collaborate with?

  Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

• How long does it take to publish a Research Topic?

  As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

  Find out more about our Research Topics

• What fee support is available to authors publishing in a Research Topic?

  Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

  Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

• Will there be a printed version of my Research Topic?

  In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.